{"title": "Under-pressure Biogen aims to please restive investors with bigger, better board", "author": "Eric Sagonowsky", "url": "https://www.fiercepharma.com/pharma/biogen-nominates-3-new-board-members-response-to-shareholder-pressure", "hostname": "fiercepharma.com", "description": "Biogen knows what it's like to confront rebellious investors. | Biogen has faced rebellious investors before. Ten years ago, it confronted a proxy fight with activist Carl Icahn that ended with two new directors on its board. So in a way, it's no surprise the biotech is expanding its board now, just a few weeks after an Alzheimer's drug flop wiped 30% off its market cap.", "sitename": "FiercePharma", "date": "2019-04-29", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}